Why has it been so hard to use CAR-T cells to treat solid tumors? Elizabeth Tracey reports
July 7, 20251m 3s
Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
For the first time CAR-T cells, a highly activated type of immune cell, have been used with some success to treat stomach cancer, a so-called solid tumor. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says solid …<p class="read-more"> <a class="more-link" href="https://podcasts.hopkinsmedicine.org/why-has-it-been-so-hard-to-use-car-t-cells-to-treat-solid-tumors-elizabeth-tracey-reports/"> <span class="screen-reader-text">Why has it been so hard to use CAR-T cells to treat solid tumors? Elizabeth Tracey reports</span> Read More »</a></p>